What does PTC Therapeutics, Inc. do?
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children and adults living with rare disorders in the United States and internationally. The company provides Translarna and Emflaza for the treatment of Duchenne muscular dystrophy;…
What is PTC Therapeutics, Inc.'s P/E and P/B ratio?
PTC Therapeutics, Inc. has a P/E ratio of -97.0 and a P/B ratio of -31.82.
What is PTC Therapeutics, Inc.'s debt-to-equity ratio?
PTC Therapeutics, Inc. has a debt-to-equity ratio of -13.19.
How much does PTC Therapeutics, Inc. owe compared with what it owns?
PTC Therapeutics, Inc. owes $1.05 for every $1 it owns (balance sheet Jun 2026), which means it owes more than it owns.
What is PTC Therapeutics, Inc.'s Positivity rank?
PTC Therapeutics, Inc. is ranked #6,688 of 6,774 companies globally and #3,924 of 4,000 in United States on PositoAI, with a Positivity Score of -48,367.
Does PTC Therapeutics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for PTC Therapeutics, Inc..
Where can I read the latest news about PTC Therapeutics, Inc.?
Recent headlines about PTC Therapeutics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does PTC Therapeutics, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of PTC Therapeutics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.